Clinical Trial Update: A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating MK-0736's effect on arterial plaque was terminated; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Vascular Disease

Drugs mentioned

• MK-0736

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Peripheral Vascular Diseases | Phase 1 | Status: TERMINATED | Results posted: 2015-02-16